Shares of GBS Inc. (NYSE:GBS – Get Free Report) dropped 3.3% on Monday . The stock traded as low as $1.75 and last traded at $1.77. Approximately 91,599 shares were traded during mid-day trading, a decline of 90% from the average daily volume of 955,325 shares. The stock had previously closed at $1.83.
GBS Stock Down 3.3%
The company has a fifty day simple moving average of $1.57 and a 200 day simple moving average of $1.65. The firm has a market capitalization of $26.36 million, a P/E ratio of -3.16 and a beta of 1.32.
About GBS
GBS Inc operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.
See Also
- Five stocks we like better than GBS
- Profitably Trade Stocks at 52-Week Highs
- These 3 Undervalued Stocks Could Surge as Value Rotation Nears
- What is the FTSE 100 index?
- Tilray Shares Blazing: What’s Behind the 55% Rally This Month?
- Consumer Staples Stocks, Explained
- 3 Retail Stocks to Watch as Back-to-School Spending Ramps Up
Receive News & Ratings for GBS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GBS and related companies with MarketBeat.com's FREE daily email newsletter.
